Pierre Sabouret: The Best Antithrombotic Strategy in Patients with Atherosclerotic Stroke and AF
Pierre Sabouret, Member of the Executive Committee for Education at European Atherosclerosis Society, shared a post on LinkedIn about a recent article he and his colleagues co-authored, adding:
“What’s the best antithrombotic strategy in patients with atherosclerotic stroke and concomitant AF? Thanks to Ahmed Ibrahim and Giuseppe Ando for this new MA together and to all amazing coauthors : B. Balba, A. Awashra, A. Shubieta, G. Cavolina, A. Villari”
Title: Optimal antithrombotic therapy for post-ischemic stroke patients with atrial fibrillation and atherosclerotic cardiovascular disease: A frequentist network meta-analysis
Authors: Ahmed Ibrahim, Elsayed Balbaa, Ameer Awashra, Abdalhakim Shubietah, Giulia Cavolina, Alessio Villari, Giuseppe Andò, Pierre Sabouret
Read the Full Article on Journal of the Neurological Sciences․
Stay updated on all scientific advances with Hemostasis Today.
-
Jun 4, 2026, 12:43Beth Wallace: Raising Awareness of Hereditary Haemochromatosis
-
Jun 4, 2026, 11:57José María Bastida Bermejo: IPDs Help to Better Understand Platelet Biogenesis and Function
-
Jun 4, 2026, 11:07Cristina Pecorilla: PSG6 and A New Approach to Cancer-Associated Thrombosis
-
Jun 4, 2026, 10:55Jacqui McCallum: Stroke Foundation Brings Stroke Advocacy to State Parliaments
-
Jun 4, 2026, 10:47Eugene Tang: Do Dementia-Predicting Scores Work for Stroke Patients?
-
Jun 4, 2026, 10:392026 National Stroke Awards Nominations Are Now Open – Stroke Foundation
-
Jun 4, 2026, 10:29Juliana Ferreira: Blogging Stroke on Exploring Early Markers of Post-Stroke Cognitive Decline
-
Jun 4, 2026, 10:20John Noble: My First Shadowing Experience in Hematology
-
Jun 4, 2026, 10:19Why Resilience Matters for Plasma-Derived Medicinal Products – PPTA Europe